文献速递骨质疏松与钙磷/甲状旁腺

轻度特发性婴儿高钙血症第二部分:纵向观察研究

Mild Idiopathic Infantile Hypercalcemia-Part 2: A Longitudinal Observational Study.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该纵向观察研究纳入20例轻度特发性婴儿高钙血症(IIH)患儿,中位随访21个月,评估限钙限维生素D饮食后的临床与生化反应。结果显示限钙饮食可改善血钙和尿钙,但1,25(OH)2D及1,25(OH)2D/PTH比值仍升高,且部分患儿肾钙化加重。CYP24A1或SLC34A1/A3变异者间反应无差异。

要点

  • 轻度IIH临床表现多样,限钙限维生素D饮食不能一致地使1,25(OH)2D正常化。
  • 限钙饮食可改善血钙和尿钙,但1,25(OH)2D/PTH比值持续升高。
  • 部分患儿肾钙化加重,治疗应针对维生素D代谢缺陷。

核心结论

  • 轻度IIH的临床表现多样,限钙限维生素D饮食不能一致地使升高的1,25(OH)2D浓度正常化,也不能预防所有病例的肾钙化加重。
  • 治疗选择应针对维生素D代谢缺陷。

研究设计与样本

  • 纵向观察性队列研究,纳入20例遗传学特征明确的轻度IIH患儿,中位监测21个月。
  • 自诊断起前瞻性每4至6个月获取生化指标、饮食评估及每年肾脏超声结果。

主要发现

  • 初始诊断中位年龄4.5个月;血清钙中位2.82 mmol/L、1,25(OH)2D中位192 pmol/L升高,血清PTH中位10 ng/L降低。
  • 尿钙/肌酐比值部分个体升高(中位1.49 mmol/mmol)。
  • 所有接受低钙饮食管理的患者血钙和尿钙指标改善,但血清1,25(OH)2D浓度及1,25(OH)2D/PTH比值仍升高。
  • 11例受试者中2例肾钙化加重;CYP24A1或SLC34A1/A3变异个体间反应无差异。

临床怎么用

  • 对轻度IIH患儿,限钙限维生素D饮食可改善血钙和尿钙,但需监测1,25(OH)2D及肾钙化变化。
  • 治疗策略应考虑针对维生素D代谢缺陷,而非仅依赖饮食限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Idiopathic infantile hypercalcemia (IIH) is an uncommon disorder with variable clinical features. The natural history and response to dietary calcium and vitamin D restriction in IIH remains unclear. OBJECTIVE: The aim of this study is to describe the clinical and biochemical response to dietary calcium and vitamin D restriction in a genetically characterized cohort of mild IIH. METHODS: This is a longitudinal, observational cohort study of 20 children with mild IIH monitored for a median of 21months. Biochemical measures, dietary assessment, and yearly renal ultrasound results, since the time of diagnosis, were obtained and assessed prospectively every 4 to 6 months. RESULTS: Median age at initial diagnosis was 4.5 months. Median levels of serum calcium (2.82 mmol/L) and 1,25 (OH)2D (192 pmol/L) were elevated, whereas serum PTH was reduced (10 ng/L). Urinary calcium:creatinine ratio was elevated for some, but not all individuals (median 1.49 mmol/mmol). All patients who were managed with a low-calcium diet showed an improvement in serum and urinary calcium measures, but the serum concentration of 1,25 dihydroxyvitamin D (1,25(OH)2D) and 1,25(OH)2D/PTH ratio remained elevated. In 2 of the 11 subjects, renal calcification worsened. There were no differences in response between individuals with CYP24A1 or SLC34A1/A3 variants. CONCLUSION: The clinical presentation of mild IIH is variable, and dietary calcium and vitamin D restriction does not consistently normalize elevated 1,25(OH)2D concentrations or prevent worsening of renal calcification in all cases. Therapeutic options should target the defect in vitamin D metabolism.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Lenherr-Taube N, Furman M, Assor E, et al. Mild Idiopathic Infantile Hypercalcemia-Part 2: A Longitudinal Observational Study. J Clin Endocrinol Metab. 2021. PMID: 34139759. doi:10.1210/clinem/dgab432

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。